CDK 4/6 Inhibitors in Metastatic Breast Cancer
1 Tampilan
administrator
07/03/23
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan